Abstract

[18F]Fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are indispensable components in modern medicine. Although PET can provide additional diagnostic value, it is costly and not universally accessible, particularly in low-income countries. To bridge this gap, we have developed a conditional generative adversarial network pipeline that can produce FDG-PET from diagnostic CT scans based on multi-center multi-modal lung cancer datasets (n = 1,478). Synthetic PET images are validated across imaging, biological, and clinical aspects. Radiologists confirm comparable imaging quality and tumor contrast between synthetic and actual PET scans. Radiogenomics analysis further proves that the dysregulated cancer hallmark pathways of synthetic PET are consistent with actual PET. We also demonstrate the clinical values of synthetic PET in improving lung cancer diagnosis, staging, risk prediction, and prognosis. Taken together, this proof-of-concept study testifies to the feasibility of applying deep learning to obtain high-fidelity PET translated from CT.

Original languageEnglish (US)
Article number101463
JournalCell Reports Medicine
Volume5
Issue number3
DOIs
StatePublished - Mar 19 2024

Keywords

  • Turing test
  • generative AI
  • generative adversarial network
  • image synthesis
  • lung cancer
  • prognostic marker
  • radiogenomics
  • radiomics
  • screening
  • synthetic PET

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept'. Together they form a unique fingerprint.

Cite this